SPEX Application
unrestricted license in the US or Canada. Board-sponsored candidates take SPEX at the request and approval ... established by the sponsoring board. Scores are reported to both the examinee and the sponsoring board
Showing 51-60 of 313 results
unrestricted license in the US or Canada. Board-sponsored candidates take SPEX at the request and approval ... established by the sponsoring board. Scores are reported to both the examinee and the sponsoring board
OF TECHNOLOGY RESOURCES AND PROGRAMS For 2024, the FSMB Foundation will award grants to state medical ... categories of awards are offered as outlined below. The deadline for application is March 29, 2024. CATEGORY
States Modifying Continuing Medical Education Requirements in Response to COVID-19
The framework is designed to assist providers in identifying issues likely to arise in the adoption ... implementation of EHRs, including the impact of adopting an EHR system on the physician-patient relationship
With a PDC data file, you have access to a comprehensive database of licensure and disciplinary information for more ... doctors (MD & DO) and physician assistants in the United States.
This report addresses accreditation standards applied to ... medical school programs located outside of the U.S. and Canada, and the feasibility of establishing criteria
(September 29, 2021) Four organizations representing the state regulatory boards that license U.S. physicians ... pharmacists, nurses and dentists have announced the launch of the Opioid Regulatory Collaborative (ORC) – a
Exploring new trends, issues and developments in Medical Regulation
(Washington, D.C., January 30, 2015) – The Federation of State Medical Boards (FSMB) is releasing ... distortions made by individuals and organizations opposing the Interstate Medical Licensure Compact, which was recently
The model policy encourages state medical boards promote the public health by making appropriate treatment ... patients, and to educate the regulatory and physician communities about the potential of new treatment